{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:06:24Z","timestamp":1790593584899,"version":"4.1.0"},"reference-count":38,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  Background:  Neoadjuvant chemotherapy is recommended as the standard of care for eligible patients with locally advanced resectable gastric adenocarcinoma. However, given the often-late diagnosis of this tumor, understanding post-neoadjuvant therapy lymph node involvement remains a determining factor in the prognosis of these patients.  Aims:  To evaluate the association between reduced tumor staging after neoadjuvant therapy and lymph node involvement in patients with gastric adenocarcinoma.  Methods:  This is a retrospective, analytical, observational study based on the medical records of patients who underwent combination therapy from 2018 to 2024. Pre-treatment clinical staging was performed according to institutional protocol, and the relationship between tumor and lymph node staging was established by comparing the initial clinical staging with the post-treatment pathological staging.  Results:  Eighty-nine patients were included in the analysis, with a reduction in tumor staging observed in 47.2% of cases, based on pathological T-cell analysis. The mean number of affected lymph nodes was significantly higher in non-responder patients compared to responders (5.0\u00b16.3 versus 1.1\u00b12.2; p&lt;0.001). Simple logistic regression analysis identified that the number of affected lymph nodes was associated with the absence of tumor response in univariate analysis, presenting an odds ratio of 1.317 (95%CI 1.099-1.579; p=0.003).  Conclusions:  The absence of reduction in tumor staging was associated with a higher residual lymph node burden, highlighting the prognostic relevance of lymph node involvement in post-therapeutic evaluation.<\/jats:p>","DOI":"10.1590\/0102-672020260000049e1978","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:50:49Z","timestamp":1790592649000},"source":"Crossref","is-referenced-by-count":0,"title":["Post-neoadjuvant therapy lymph node response in patients with gastric adenocarcinoma"],"prefix":"10.1590","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8299-2514","authenticated-orcid":false,"given":"Geraldo","family":"ISHAK","sequence":"first","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-5250","authenticated-orcid":false,"given":"Luciana Roberta do Vale","family":"CORR\u00caA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3667-8453","authenticated-orcid":false,"given":"Thaygo de Azevedo","family":"NEVES","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-8584","authenticated-orcid":false,"given":"Ricardo Ormanes","family":"MASSOUD","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2942-1936","authenticated-orcid":false,"given":"Ives Uch\u00f4a de","family":"AZEVEDO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3103-975X","authenticated-orcid":false,"given":"Pedro Ant\u00f4nio Mufarrej","family":"HAGE","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-4212","authenticated-orcid":false,"given":"Williams Fernandes","family":"BARRA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-8445","authenticated-orcid":false,"given":"Paulo Pimentel de","family":"ASSUMP\u00c7\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1","place":["Bel\u00e9m, PA, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","article-title":"Gastric cancer, Version 2.2025. NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Ajani JA","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"10184","key":"ref2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial","volume":"393","author":"Al-Batran SE","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"ref3","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker K","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ejso.2015.03.227","article-title":"Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?","volume":"41","author":"Biondi A","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s10120-011-0115-4","article-title":"A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer","volume":"15","author":"Cardoso R","year":"2012","journal-title":"Gastric Cancer"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12876-025-03594-8","article-title":"Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis","volume":"25","author":"Chen Y","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3747\/co.24.3736","article-title":"Staging and surgical approaches in gastric cancer: a clinical practice guideline","volume":"24","author":"Coburn N","year":"2017","journal-title":"Curr Oncol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade","volume":"13","author":"Correa P","year":"2012","journal-title":"J Dig Dis"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham D","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/dmr-22-34","article-title":"Tumor regression grade (TRG) for gastric cancer and radiological methods on predicting response: a narrative review","volume":"6","author":"Garbarino GM","year":"2023","journal-title":"Dig Med Res"},{"key":"ref12","article-title":"Optimal upfront surgery for gastric adenocarcinoma. Real life situation in Brazil. Results comparable to neoadjuvant treatment","volume":"38","author":"Gon\u00e7alves AC","year":"2026","journal-title":"Arq Bras Cir Dig"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11605-017-3633-5","article-title":"Gastrectomy with extended lymphadenectomy: a North American perspective","volume":"22","author":"Gosselin-Tardif A","year":"2018","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7326\/0003-4819-97-2-272","article-title":"Early gastric cancer","volume":"97","author":"Green PH","year":"1982","journal-title":"Ann Intern Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11605-018-3764-3","article-title":"Central lymph node metastasis in gastric cancer is predictive of survival after preoperative therapy","volume":"22","author":"Ikoma N","year":"2018","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.21037\/tgh.2016.09.08","article-title":"Pathologic tumor response to neoadjuvant chemotherapy in gastroesophageal cancer: what does it mean?","volume":"1","author":"Kosuga T","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"151398","DOI":"10.1016\/j.soncn.2023.151398","article-title":"An overview of the fundamentals of data management, analysis, and interpretation in quantitative research","volume":"39","author":"Kotronoulas G","year":"2023","journal-title":"Semin Oncol Nurs"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-017-2232-x","article-title":"Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy","volume":"472","author":"Langer R","year":"2018","journal-title":"Virchows Arch"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1007\/s10120-011-0047-z","article-title":"A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer","volume":"15","author":"Leake PA","year":"2012","journal-title":"Gastric Cancer"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11605-023-05641-9","article-title":"Systematic review and meta-analysis of the outcomes following neoadjuvant therapy in upfront resectable gastric cancers compared to surgery alone in phase III randomised controlled trials","volume":"27","author":"Shin ALK","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick F","year":"2022","journal-title":"Ann Oncol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.sla.0000250423.43436.e1","article-title":"The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients","volume":"245","author":"Marchet A","year":"2007","journal-title":"Ann Surg"},{"key":"ref24","series-title":"Statistical analysis with SPSS Statistics","author":"Mar\u00f4co J","year":"2018","edition":"7\u00aa ed"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.2016.252","article-title":"Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer","volume":"115","author":"Martin-Romano P","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"104134","DOI":"10.1016\/j.esmoop.2025.104134","article-title":"ESMO clinical practice guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma","volume":"10","author":"Obermannov\u00e1 RL","year":"2025","journal-title":"ESMO Open"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1590\/0102-6720202400031e1824","article-title":"Ratio of metastatic lymph nodes vs. resected lymph nodes (n-ratio) has prognostic implications in gastric cancer","volume":"37","author":"Porto BC","year":"2024","journal-title":"Arq Bras Cir Dig"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/cancers11121914","article-title":"The role of the lymph node ratio in advanced gastric cancer after neoadjuvant chemotherapy","volume":"11","author":"Rawicz-Pruszy\u0144ski K","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cjp2.169","article-title":"Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas","volume":"6","author":"Reim D","year":"2020","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","DOI":"10.32635\/2176-9745.RBC.2023v69n1.3700","article-title":"Estimated cancer incidence in Brazil, 2023-2025","volume":"69","author":"Santos MO","year":"2023","journal-title":"Rev Bras Cancerol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1007\/s10120-012-0169-y","article-title":"How many lymph nodes should be assessed in patients with gastric cancer? A systematic review","volume":"15","author":"Seevaratnam R","year":"2012","journal-title":"Gastric Cancer"},{"issue":"23","key":"ref32","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1200\/JCO.2015.65.7692","article-title":"Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial","volume":"34","author":"Smyth EC","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref33","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fonc.2013.00262","article-title":"Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment","volume":"3","author":"Thies S","year":"2013","journal-title":"Front Oncol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diagnostics11010134","article-title":"Endoscopic ultrasound vs. computed tomography for gastric cancer staging: a network meta-analysis","volume":"11","author":"Ungureanu BS","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijsu.2018.08.002","article-title":"Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis","volume":"57","author":"Zhu J","year":"2018","journal-title":"Int J Surg"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5230\/jgc.2021.21.e5","article-title":"Prognostic value of lymph node ratio after neoadjuvant chemotherapy in patients with locally advanced gastric adenocarcinoma","volume":"21","author":"Zhu K","year":"2021","journal-title":"J Gastric Cancer"},{"issue":"3","key":"ref38","first-page":"147","article-title":"Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges","volume":"6","author":"Zhu Z","year":"2020","journal-title":"Chronic Dis Transl Med"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202026000100630&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:50:53Z","timestamp":1790592653000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202026000100630&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":38,"alternative-id":["S0102-67202026000100630"],"URL":"https:\/\/doi.org\/10.1590\/0102-672020260000049e1978","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e1978"}}